CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT.  With ICM, they will improve affordability and accessibility of pharmaceuticals on a global scale.

Pharmaceutical

CONTINUUS Pharmaceuticals

Salvatore Mascia

Priya Bharate

Keith Barbato

Janaka Gamekkanda

Fang Yu

Chuntian Hu

Wei Wu

Randall Goyette

Youhua Li

Elizabeth (Liz) Pool, SHRM-SCP

Leonardo Vincenzi

John Costello, CQA

Jason Whipp

Graham Dreamer

Donald Lohman

Dean Hopkins

Bhakti Halkude

Bayan Takizawa

The board of directors at CONTINUUS Pharmaceuticals has a history of experience in the financial sector of various Biotech companies. A few examples include Arbor Biotechnologies, Inceptor Bio, Arranta Bio, and Brammer Bio. The board is also educated, with degrees in fields such as business administration and accounting.

Board of Directors

CEO and Executive Team

Founding Team

Board of Directors

About

Team members

Other teams at CONTINUUS Pharmaceuticals

CEO and Executive Team

Founding Team